Better Money Decisions’s AbbVie ABBV Stock Holding History

Better Money Decisions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,727	Closed	-$275K	–	64
2023 Q1	$275K	Sell	1,727 -8	-0.5%	-$1.22K	0.23%	51
2022 Q4	$280K	Buy	+1,735	New	+$266K	0.24%	53
2022 Q3	–	Sell	-65	Closed	-$10K	–	59
2022 Q2	$10K	Buy	+65	New	+$9.93K	0.01%	309
2021 Q4	–	Sell	-145	Closed	-$16K	–	67
2021 Q3	$16K	Buy	145 +1	+0.7%	+$114	0.01%	310
2021 Q2	$16K	Buy	144 +51	+55%	+$5.74K	0.01%	297
2021 Q1	$10K	Buy	+93	New	+$9.95K	0.01%	332

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Better Money Decisions's ABBV Position: Q2 2023 in Review

Better Money Decisions sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 1,727 shares — an estimated $275K sold.

Better Money Decisions first reported a position in ABBV in Q1 2021 and held it in 6 quarters. The position peaked at $280K in Q4 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Better Money Decisions reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
Better Money Decisions sold 1,727 AbbVie shares in Q2 2023, an estimated $275K.
Better Money Decisions first reported a position in AbbVie in Q1 2021 and held it in 6 quarters.
Better Money Decisions's AbbVie position peaked at $280K in Q4 2022.
3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Better Money Decisions's 13F filing for Q2 2023, filed 9 Aug 2023.